The Holographic Standardized Patient

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-100
SponsorSunnybrook Health Sciences Centre

About this trial

The current pandemic has revealed in-person simulation training and evaluation is vulnerable to disruption, and alternatives are needed which allow remote evaluation. The recently developed Microsoft Hololens headset device allows interactable holograms to be inserted into a user's workspace (mixed reality) - permitting the augmentation of existing clinical and training spaces with holographic (i.e. virtual) patients via the prototype HoloSIM software. This study is the first known research initiative aiming to demonstrate the feasibility and effectiveness of mixed reality for acute medicine training and assessment at a distance.

Space, time, personnel, pandemic, and cost constraints limit opportunities for high-fidelity simulation exercises for post-graduate trainees at Sunnybrook. By developing and demonstrating the effectiveness of this new training modality, increased simulation exercises will lead to a higher quality education experience, better functioning teams, and better patient outcomes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Resident or fellow level volunteers from acute care postgraduate training programs (Internal Medicine, Emergency Medicine, Anesthesiology, Critical Care Medicine at Sunnybrook Health Sciences Centre

Disqualifiers

Unwilling to enter the study

Previous experience with simulator based teaching on anaphylaxis

Trial design

Design model

Parallel

Treatments tested in this trial

  • HoloSIM Software via Hololens 2

    Device

    Participants will train via a mixed reality simulated crisis scenario using the HoloSIM software on the Microsoft Hololens 2

  • Training by Mannequin Based Simulation

    Other intervention

    Participants will train a via traditional mannequin based medical crisis scenario

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Group A: HoloSIM (intervention)Experimental treatment 1 intervention
Group B: Group B: Mannequin (control)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Anaphylaxis Checklist of Core Decision Making Steps

Expert consensus based checklists of critical scenario actions on a mannequin based crisis scenario. Student scenario performance graded from 0 to 45, with higher scores representing a better performance.

Time frame
30 days post exposure

Secondary outcomes

1

System Usability Scale (SUS)

Likert scale (5 point) based assessment of software usability. Higher scores on a scale of 1 to 5 represent a better software system usability.

Time frame
Immediately after exposure
2

Modified Simulation Effectiveness Tool (SET-M)

likert scale (3 point) validated assessment of learning satisfaction tool

Time frame
Immediately after exposure
3

Time required to complete critical crisis related tasks

Measured time until critical scenario management events occur

Time frame
30 days post exposure
4

anaphylaxis knowledge test

validated multiple choice quiz of anaphylaxis knowledge developed by allergists for use with the same curriculum included in our study

Time frame
30 days post exposure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.